Hims & Hers (HIMS), the millennial-skewed telehealth company, saw its stock tumble nearly 9% on Tuesday, as the company ...

FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 – glucagon-like peptide-1 receptor agonists – drugs, including semaglutide and tirzepatide, as an ...

Newton Mayor Ruthanne Fuller rejected Superintendent Anna Nolin’s request for a $14.9 million funding increase for NPS next ...

YouTube just announced their latest crackdown which involves content that is luring viewers to gambling sports betting ...

EVIT sues Adelante Healthcare over an allegedly illegal lease on its Mesa campus, disputing approval and rent discrepancies.